Cytoproliferative activity in colorectal poorly differentiated clusters: Biological significance in tumor setting

Ann Diagn Pathol. 2021 Aug:53:151772. doi: 10.1016/j.anndiagpath.2021.151772. Epub 2021 Jun 16.

Abstract

Background: Poorly differentiated clusters (PDCs) have gained a significant prognostic role in colorectal carcinomas (CRCs) being associated to high risk of lymph node metastasis, shorter survival time and poor prognosis. The knowledge in PDC biology is not completely clear.

Materials and methods: We assessed Ki-67 LI in 45 CRCs showing ≥10 PDCs. We distinguished PDCs at the periphery of the tumor masses (pPDCs) from those within the tumor masses (cPDCs). We chose 3 cut-offs of Ki-67 labeling index (Ki-67 LI): <10%, 10-50%, and >50% of the labeled cells.

Results: Ki-67 LI in pPDCs was<10% in 37 cases (82%), 10-50% in 6 cases (13%) and >50%in 2 cases (5%); Ki-67 LI in cPDCs was<10% in 4 cases (23.5%), 10-50% in 4 (23.5%) and >50% in 9 (54%). Ki-67 LI in tumor budding foci (TBs) was <10% in 8 cases (32%), 10-50% in 8 (32%) and >50% in 9 (36%). The difference of Ki-67 LI reaches the statistical significance (p < 0.005). Ki-67 LI <10% in the pPDCs was associated with nodal metastases (pN+) (p < 0.0001), pTNM stage III and IV(p < 0.0001) and TB (p < 0.001). Ki-67 LI > 50% in cPDC was significantly associated withpT3-pT4 and advanced pTNM stages (p < 0.0001), N+ (p = 0.0001) and LVI (p < 0.05).

Conclusion: Different Ki-67 LI detected between cPDCs and pPDCs suggesting a biological difference in PDCs. An actively proliferating central tumor areas can be distinguished from the peripheral portion of the tumors in which the cells interact with the stroma acquiring invasive and metastatic potential.

Keywords: Colorectal carcinoma; Ki-67; MIB-1; PDC; Poorly differentiated clusters.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Antinuclear / immunology
  • Antibodies, Monoclonal / immunology
  • Biomarkers, Tumor / metabolism
  • Cell Differentiation
  • Cell Proliferation
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / metabolism*
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / pathology*
  • Female
  • Humans
  • Immunohistochemistry / methods
  • Ki-67 Antigen / metabolism*
  • Lymphatic Metastasis / pathology*
  • Male
  • Middle Aged
  • Neoplasm Staging / methods
  • Prognosis
  • Risk Factors
  • Survival Rate / trends

Substances

  • Antibodies, Antinuclear
  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • Ki-67 Antigen
  • MIB-1 antibody